Clinical Trial Update: Quantitative Refractive Crosslinking in Presbyopia Aged Patients [NA]

View source ↗

Summary

Clinical Trial Update: TECLens is testing Quantitative Refractive Crosslinking for presbyopia, with the study currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Presbyopia

Drugs mentioned

• Quantitative Refractive Crosslinking

Snippet

Sponsor: TECLens, Inc. | Conditions: Presbyopia | NA | Status: NOT_YET_RECRUITING